Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 220S220 trades$52.89M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
MSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
FFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
MGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 2 | Faga DanielDirector, President, CEO |  ANABANAPTYSBIO, INCDisposition to issuer | D | — 379.6K sh | Apr 22, 2026 |
| 2 | Faga DanielDirector, President, CEO | ANABANAPTYSBIO, INC Disposition to issuer | D | — 133.4K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 2 | Kuykendall AnneSVP and Chief Legal Officer |  PENGPenguin Solutions, Inc.Tax withholding · 10b5-1 plan | F | $82K 3,062 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 2 | Faga DanielDirector, President, CEO | ANABANAPTYSBIO, INC Disposition to issuer | D | — 194.9K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 2 | Faga DanielDirector, President, CEO | ANABANAPTYSBIO, INC Disposition to issuer | D | — 305.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 2 | Faga DanielDirector, President, CEO | ANABANAPTYSBIO, INC Disposition to issuer | D | — 9,200 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 2 | Faga DanielDirector, President, CEO | ANABANAPTYSBIO, INC Grant or award | A | — 9,200 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 2 | Faga DanielDirector, President, CEO | ANABANAPTYSBIO, INC Grant or award | A | — 379.6K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 2 | Faga DanielDirector, President, CEO | ANABANAPTYSBIO, INC Grant or award | A | — 194.9K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 1 | Freemen-Bosworth LaurenEVP/Gen Counsel & Corp Sec |  PBIPITNEY BOWES INC /DE/Open-market sale · 10b5-1 plan | SELL | $2,408 169 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 1 | Cross ShawnChief Financial Officer |  PCRXPacira BioSciences, Inc.Open-market sale · 10b5-1 plan | SELL | $38K 1,500 sh | Apr 22, 2026 traded Apr 22, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 33.3K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 900.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Cross ShawnChief Financial Officer | PCRXPacira BioSciences, Inc. Option exercise · 10b5-1 plan | M | $25K 1,500 sh | Apr 22, 2026 traded Apr 22, 2026 |
| 0 | Cross ShawnChief Financial Officer | PCRXPacira BioSciences, Inc. Option exercise · 10b5-1 plan | M | — 7,714 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder |  HNGEHinge Health, Inc.Derivative conversion · 10b5-1 plan | C | — 33.3K sh | Apr 22, 2026 traded Apr 21, 2026 |
| 0 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner |  DSPViant Technology Inc.Option exercise · 10b5-1 plan | M | — 12.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 54.2K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 33.3K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 200.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Capital V LLC10% Owner | DSPViant Technology Inc. Option exercise · 10b5-1 plan | M | — 37.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Cross ShawnChief Financial Officer | PCRXPacira BioSciences, Inc. Option exercise · 10b5-1 plan | M | — 2,845 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 0 | Okupe OluyemiChief Financial Officer |  HIMSHims & Hers Health, Inc.Option exercise · 10b5-1 plan | M | — 5,553 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Capital V LLC10% Owner | DSPViant Technology Inc. Option exercise · 10b5-1 plan | M | — 37.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 225.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Okupe OluyemiChief Financial Officer | HIMSHims & Hers Health, Inc. Option exercise · 10b5-1 plan | M | $81K 7,000 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 225.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Okupe OluyemiChief Financial Officer | HIMSHims & Hers Health, Inc. Option exercise · 10b5-1 plan | M | $28K 5,553 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Sehmi HarminderChief Financial Officer |  BZAIBlaize Holdings, Inc.Option exercise · 10b5-1 plan | M | — 505.1K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Venker EricPresident & Immunovant CEO |  ROIVRoivant Sciences Ltd.Option exercise · 10b5-1 plan | M | — 200.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Arora TarunChief Accounting Officer |  RNGRingCentral, Inc.Open-market sale · 10b5-1 plan | SELL | $41K 953 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 12.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | DSPViant Technology Inc. Option exercise · 10b5-1 plan | M | — 12.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Derivative conversion · 10b5-1 plan | C | — 33.3K sh | Apr 22, 2026 traded Apr 21, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 12.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 33.3K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Adarkar PrabirPRESIDENT AND COO | DASHDoorDash, Inc. Option exercise · 10b5-1 plan | M | — 10.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Adarkar PrabirPRESIDENT AND COO | DASHDoorDash, Inc. Grant or award · 10b5-1 plan | A | — 144.3K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Adarkar PrabirPRESIDENT AND COO | DASHDoorDash, Inc. Option exercise · 10b5-1 plan | M | $72K 10.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 33.3K sh | Apr 22, 2026 traded Apr 20, 2026 |